Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marwan Fakih

Showing results (131-140 of 200) with videos related to

Pageof 20
Sort By:
International Journal of Radiation Oncology, Biology, Physics|February 6, 2010
Renal atrophy secondary to chemoradiotherapy of abdominal malignanciesGary Y Yang, Kilian Salerno May, Renuka V Iyer, et al.
Frontiers in Oncology|March 6, 2023
Targeting fat mass and obesity-associated protein mitigates human colorectal cancer growth <i>in vitro</i> and in a murine modelThuy Phan, Vu H Nguyen, Rui Su, et al.
Journal of Vascular and Interventional Radiology : JVIR|June 17, 2024
Multidisciplinary Delphi Consensus on Safety of Combining Transarterial Radioembolization with Yttrium-90 Microspheres with Systemic Anticancer Agents for the Treatment of Liver MalignancyAndrew S Kennedy, Daniel B Brown, Marwan Fakih, et al.
The Oncologist|August 6, 2021
Recall of Genomic Testing Results Among Patients with CancerSam E Wing, Hengrui Hu, Lisa Lopez, et al.
Clinical Colorectal Cancer|May 22, 2026
Matching-Adjusted Indirect Comparison of Sotorasib Plus Panitumumab Versus Trifluridine/Tipiracil Plus Bevacizumab in Chemorefractory Metastatic Colorectal CancerLisa Salvatore, Marwan Fakih, Yasutoshi Kuboki, et al.
Cancer|October 15, 2013
TRAIL receptor agonist conatumumab with modified FOLFOX6 plus bevacizumab for first-line treatment of metastatic colorectal cancer: A randomized phase 1b/2 trialCharles S Fuchs, Marwan Fakih, Lee Schwartzberg, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 2022
Evaluation of pembrolizumab monotherapy in patients with previously treated advanced salivary gland carcinoma in the phase 2 KEYNOTE-158 studyCaroline Even, Jean-Pierre Delord, Katharine A Price, et al.
Frontiers in Oncology|May 7, 2020
The Role of Palliative Surgery for Malignant Bowel Obstruction and Perforation in Advanced Microsatellite Instability-High Colorectal Carcinoma in the Era of Immunotherapy: Case ReportSean J Judge, Jingran Ji, James Liu, et al.
The Oncologist|September 30, 2016
Broad Detection of Alterations Predicted to Confer Lack of Benefit From EGFR Antibodies or Sensitivity to Targeted Therapy in Advanced Colorectal CancerAndrew Rankin, Samuel J Klempner, Rachel Erlich, et al.
Journal of Primary Care & Community Health|June 9, 2022
Cancer Survivors, Oncology, and Primary Care Perspectives on Survivorship Care: An Integrative ReviewMadeleine Love, Marc Debay, Anne Charity Hudley, et al.
Pageof 20

Showing results (131-140 of 200) with videos related to

Sort By:
Pageof 20
International Journal of Radiation Oncology, Biology, Physics|February 6, 2010
Renal atrophy secondary to chemoradiotherapy of abdominal malignanciesGary Y Yang, Kilian Salerno May, Renuka V Iyer, et al.
Frontiers in Oncology|March 6, 2023
Targeting fat mass and obesity-associated protein mitigates human colorectal cancer growth <i>in vitro</i> and in a murine modelThuy Phan, Vu H Nguyen, Rui Su, et al.
Journal of Vascular and Interventional Radiology : JVIR|June 17, 2024
Multidisciplinary Delphi Consensus on Safety of Combining Transarterial Radioembolization with Yttrium-90 Microspheres with Systemic Anticancer Agents for the Treatment of Liver MalignancyAndrew S Kennedy, Daniel B Brown, Marwan Fakih, et al.
The Oncologist|August 6, 2021
Recall of Genomic Testing Results Among Patients with CancerSam E Wing, Hengrui Hu, Lisa Lopez, et al.
Clinical Colorectal Cancer|May 22, 2026
Matching-Adjusted Indirect Comparison of Sotorasib Plus Panitumumab Versus Trifluridine/Tipiracil Plus Bevacizumab in Chemorefractory Metastatic Colorectal CancerLisa Salvatore, Marwan Fakih, Yasutoshi Kuboki, et al.
Cancer|October 15, 2013
TRAIL receptor agonist conatumumab with modified FOLFOX6 plus bevacizumab for first-line treatment of metastatic colorectal cancer: A randomized phase 1b/2 trialCharles S Fuchs, Marwan Fakih, Lee Schwartzberg, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 2022
Evaluation of pembrolizumab monotherapy in patients with previously treated advanced salivary gland carcinoma in the phase 2 KEYNOTE-158 studyCaroline Even, Jean-Pierre Delord, Katharine A Price, et al.
Frontiers in Oncology|May 7, 2020
The Role of Palliative Surgery for Malignant Bowel Obstruction and Perforation in Advanced Microsatellite Instability-High Colorectal Carcinoma in the Era of Immunotherapy: Case ReportSean J Judge, Jingran Ji, James Liu, et al.
The Oncologist|September 30, 2016
Broad Detection of Alterations Predicted to Confer Lack of Benefit From EGFR Antibodies or Sensitivity to Targeted Therapy in Advanced Colorectal CancerAndrew Rankin, Samuel J Klempner, Rachel Erlich, et al.
Journal of Primary Care & Community Health|June 9, 2022
Cancer Survivors, Oncology, and Primary Care Perspectives on Survivorship Care: An Integrative ReviewMadeleine Love, Marc Debay, Anne Charity Hudley, et al.
Pageof 20